[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@RedChip Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::25292321.png) @RedChip RedChip

RedChip appears to be hosting investor webinars with various companies, including Bullfrog AI ($BFRG), Calidi Biotherapeutics ($CLDI), Fathom Holdings ($FTHM), and Fibrobiologics ($FBLG). These webinars aim to provide insights into the companies' growth strategies, innovative approaches, and future prospects. RedChip also introduced RedChat, a new platform for small-cap research that provides instant answers and verified data.

### Engagements: XXXXXX [#](/creator/twitter::25292321/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25292321/c:line/m:interactions.svg)

- X Week XXXXXXX -XX%
- X Month XXXXXXXXX +162%
- X Months XXXXXXXXX +2,024%
- X Year XXXXXXXXX +621%

### Mentions: XX [#](/creator/twitter::25292321/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25292321/c:line/m:posts_active.svg)

- X Week XXX +32%
- X Month XXX -XX%
- X Months XXXXX +381%
- X Year XXXXX +581%

### Followers: XXXXX [#](/creator/twitter::25292321/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25292321/c:line/m:followers.svg)

- X Week XXXXX +0.46%
- X Month XXXXX +1.70%
- X Months XXXXX +9.70%
- X Year XXXXX +13%

### CreatorRank: XXXXXXX [#](/creator/twitter::25292321/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25292321/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::25292321/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  #5372 [technology brands](/list/technology-brands)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  #5018 [automotive brands](/list/automotive-brands)  XXXX% [countries](/list/countries)  XXXX% [currencies](/list/currencies)  XXXX% [exchanges](/list/exchanges)  XXXX%

**Social topic influence**
[$ltrn](/topic/$ltrn) #1, [$abbv](/topic/$abbv) #2, [$gild](/topic/$gild) #1, [$fatn](/topic/$fatn) #1, [$sdgr](/topic/$sdgr) #1, [$rxrx](/topic/$rxrx) #1, [$nvda](/topic/$nvda) #132, [$bfrg](/topic/$bfrg) #1, [$mrna](/topic/$mrna) #1, [$xrtx](/topic/$xrtx) #4

**Top accounts mentioned or mentioned by**
[@novaminerals](/creator/undefined) [@aspisotopes](/creator/undefined) [@greenpowerbus](/creator/undefined) [@lanternpharma](/creator/undefined) [@gorillatechgrp](/creator/undefined) [@canfitepharma](/creator/undefined) [@fatpipeinc](/creator/undefined) [@jcventerinst](/creator/undefined) [@lieberinstitute](/creator/undefined) [@trinitybiotech](/creator/undefined) [@atossainc](/creator/undefined) [@calidibio](/creator/undefined) [@cirmnews](/creator/undefined) [@northwesternu](/creator/undefined) [@cityofhope](/creator/undefined) [@thelancet](/creator/undefined) [@greenwichls](/creator/undefined) [@niocorp](/creator/undefined) [@xtiaerospace](/creator/undefined) [@nasdaqbtcs](/creator/undefined)

**Top assets mentioned**
[AbbVie Inc (ABBV)](/topic/$abbv) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Schrodinger, Inc. Common Stock (SDGR)](/topic/$sdgr) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Moderna Inc (MRNA)](/topic/$mrna) [Boyd Gaming Corporation (BYD)](/topic/$byd) [Oracle Corporation (ORCL)](/topic/$orcl) [Broadcom, Inc. (AVGO)](/topic/$avgo) [Cisco Systems Inc (CSCO)](/topic/$csco) [Fortinet Inc (FTNT)](/topic/$ftnt) [Frontier Communications Parent, Inc. Common Stock (FYBR)](/topic/$fybr) [Datadog Inc (DDOG)](/topic/$ddog) [Hewlett Packard Enterprise Co (HPE)](/topic/$hpe) [Crowdstrike Holdings Inc (CRWD)](/topic/$crwd) [Pfizer, Inc. (PFE)](/topic/$pfe) [DraftKings Inc. Class A Common Stock (DKNG)](/topic/$dkng) [MGM Resorts International (MGM)](/topic/$mgm) [Las Vegas Sands Corp. (LVS)](/topic/$lvs) [Wynn Resorts, Limited (WYNN)](/topic/$wynn) [PENN Entertainment Inc (PENN)](/topic/$penn) [Caesars Entertainment, Inc. (CZR)](/topic/$czr) [Infinitar (IGT)](/topic/$igt) [VICI Properties, Inc. (VICI)](/topic/$vici) [Bitcoin Scrypt (BTCS)](/topic/$btcs) [Ethereum (ETH)](/topic/ethereum) [Levante U.D. Fan Token (LEV)](/topic/$lev) [Tesla, Inc. (TSLA)](/topic/$tsla) [Rivian Automotive, Inc. (RIVN)](/topic/$rivn) [Nexus ASA (GP)](/topic/$gp) [Amgen, Inc. (AMGN)](/topic/$amgn) [AstraZeneca PLC (AZN)](/topic/$azn) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [Johnson & Johnson (JNJ)](/topic/$jnj) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Eli Lilly and Company (LLY)](/topic/$lly) [Novartis AG (NVS)](/topic/$nvs) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [MP Materials Corp. (MP)](/topic/$mp) [Perpetua Resources Corp. Common Shares (PPTA)](/topic/$ppta) [Teck Resources Limited (TECK)](/topic/$teck) [Kinross Gold Corporation (KGC)](/topic/$kgc) [NovaGold Resources Inc. (NG)](/topic/$ng) [Hecla Mining Company (HL)](/topic/$hl) [Ninja Squad Token (NST)](/topic/$nst) [Gold (XAU)](/topic/$xau)
### Top Social Posts [#](/creator/twitter::25292321/posts)
---
Top posts by engagements in the last XX hours

"📢 Foremost Clean Energy $FMST: Strategic Advantage in the Athabasca Basin In our latest interview CEO Jason Barnard highlights how @FMSTCleanEnergy's partnership with Denison Mines $DNN and proximity to world-class producers like Cameco set the stage for outsized upside: Why This Matters for Investors: 330000+ acres across XX properties in the Athabasca Basin one of the richest uranium districts in the world Fully funded $6.5M exploration program in 2025 with active drill campaigns at Murphy Lake and Hatchet Lake Direct access to Denisons ISR expertise and data advantage accelerating"  
[X Link](https://x.com/RedChip/status/1973742326359957783) [@RedChip](/creator/x/RedChip) 2025-10-02T13:30Z 5899 followers, 54K engagements


"📢 Foremost Clean Energy $FMST: Strategic Advantage in the Athabasca Basin In our latest interview CEO Jason Barnard highlights how @FMSTCleanEnergy's partnership with Denison Mines $DNN and proximity to world-class producers like Cameco set the stage for outsized upside: Why This Matters for Investors: 330000+ acres across XX properties in the Athabasca Basin one of the richest uranium districts in the world Fully funded $6.5M exploration program in 2025 with active drill campaigns at Murphy Lake and Hatchet Lake Direct access to Denisons ISR expertise and data advantage accelerating"  
[X Link](https://x.com/RedChip/status/1976279049262534940) [@RedChip](/creator/x/RedChip) 2025-10-09T13:30Z 5899 followers, 54.6K engagements


"🛫 @XTIAerospace $XTIA: Unveiling the Future of Regional Air Mobility CEO Scott Pomeroy outlines how the TriFan XXX is positioned to transform both commercial and government aviation with unmatched versatility: VTOL flexibility + business turboprop speed and range Nearly 1000-mile missions at 300+ mph without new infrastructure Early market validation: 140+ conditional pre-orders and XXX reservations/options representing $3B potential revenue Why It Matters for Investors: The TriFan XXX addresses a massive market gap between short-range eVTOLs and traditional fixed-wing aircraft with"  
[X Link](https://x.com/RedChip/status/1977755009400836269) [@RedChip](/creator/x/RedChip) 2025-10-13T15:15Z 5899 followers, 55K engagements


"📺 FatPipe: Watch our 30-Second Investor Overview @FatPipe_Inc $FATN a pioneer in secure networking is scaling its enterprise-grade SD-WAN and SASE solutions across North America and Southeast Asia. Key Highlights for Investors: FY24 Revenue: $17.9M Net Income: $4.4M (24.4% margin) 2500+ customers across government finance healthcare and retail Expanding footprint in Southeast Asia & Mexico Positioned in a $49B+ market growing at double-digit CAGR With patented technology a 90%+ gross margin SaaS model and proven profitability $FATN offers exposure to cutting-edge mission-critical enterprise"  
[X Link](https://x.com/RedChip/status/1978089664062836790) [@RedChip](/creator/x/RedChip) 2025-10-14T13:25Z 5899 followers, 55K engagements


"⚛ Greenwich LifeSciences $GLSI: A Quick Look at a Promising Phase III Breast Cancer Therapy @GreenwichLS is making major strides in the fight against breast cancer. Its lead immunotherapy candidate GLSI-100 is now in a global Phase III trial (FLAMINGO-01) spanning XXX sites across the U.S. and Europe targeting up to XXX HER2+ breast cancer patients. Why This Matters to Investors: Breakthrough Potential: Aims to reduce recurrence rates by over XX% outperforming current HER2 therapies. Robust Safety Profile: Supported by ongoing Data Safety Monitoring Board reviews with no changes required."  
[X Link](https://x.com/RedChip/status/1978093442627457045) [@RedChip](/creator/x/RedChip) 2025-10-14T13:40Z 5899 followers, 54.9K engagements


"🎙 Investor Spotlight: Geoff Dow CEO of XX Degrees Pharmaceuticals $SXTP Shares Strategic Vision $SXTP is taking aim at infectious diseases with precision. In our latest interview President & CEO Geoff Dow discusses how $SXTP is advancing its antifungal and antiviral pipeline while scaling commercialization of ARAKODA: an FDA-approved malaria prophylactic with XXX% YoY sales growth in Q3 2024. Why Investors Should Tune In: Strong Market Traction: ARAKODA is revenue-generating and FDA-approved with growth accelerating. Strategic Expansion: Upcoming pivotal study in babesiosis a tick-borne"  
[X Link](https://x.com/RedChip/status/1978474732505739457) [@RedChip](/creator/x/RedChip) 2025-10-15T14:55Z 5899 followers, 40.7K engagements


"🧬 $LTRN: Rapid Pipeline Expansion @LanternPharma has launched XX new drug development programs in the last X years rapidly growing its oncology portfolio. Why This Matters to Investors: XX programs initiated since 2023 Active Phase 1/2 trials across multiple cancers Expanding pipeline broadens R&D risk profile Learn more: $LTRN $SDGR $RXRX $NVDA $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1978477232960970797) [@RedChip](/creator/x/RedChip) 2025-10-15T15:05Z 5899 followers, 40.7K engagements


"🔬 BullFrog AI $BFRG: Transforming Drug Development with AI Join BullFrog AI CEO Vin Singh on October XX at 4:15 PM ET for a live Investor Webinar. Hear how BullFrogs proprietary bfLEAP platform and BullFrog Data Networks are driving precision in drug discovery and clinical trial optimization: addressing a $200B market opportunity in biopharma R&D. Dont miss this inside look at how BullFrog AI is positioned for long-term growth. Register Now: @JCVenterInst @LieberInstitute $BFRG $ABBV $GILD $MRNA $SDGR $RXRX $NVDA"  
[X Link](https://x.com/RedChip/status/1978818987371659580) [@RedChip](/creator/x/RedChip) 2025-10-16T13:43Z 5898 followers, XXX engagements


"🤖 Lantern Pharma $LTRN: AI is accelerating safer more precise oncology drug development Whats powering the story: RADR leverages 200B plus oncology datapoints to identify candidates optimize patient targeting and cut early development time by XX% and cost by up to 80%. XX programs launched in XX months with patient response predictions validated at greater than XX% accuracy. Three clinical assets advancing: LP-300 Phase X in never-smoker NSCLC LP-184 Phase X in multiple solid tumors including GBM with Fast Track and Orphan designations and LP-284 Phase X for aggressive B-cell lymphomas with"  
[X Link](https://x.com/RedChip/status/1978824076069065100) [@RedChip](/creator/x/RedChip) 2025-10-16T14:03Z 5899 followers, 52K engagements


"🔬 Chemical & Engineering News this week underscored what every serious biotech investor knows: AI is now everywhere in drug discovery but messy siloed data remains the biggest barrier to progress. BullFrog AI $BFRG is solving that problem with bfPREP a new module in its BullFrog Data Networks platform that automates the cleansing standardization and preparation of complex biomedical datasets turning raw fragmented information into AI-ready insights. Its the foundation AI needs to actually work in drug development. Learn more at $BFRG $ABBV $GILD $MRNA $SDGR $RXRX $NVDA"  
[X Link](https://x.com/RedChip/status/1978869605251547463) [@RedChip](/creator/x/RedChip) 2025-10-16T17:04Z 5899 followers, XXX engagements


"Read the full C&E News deep dive to learn more about the challenges $BFRG is addressing:"  
[X Link](https://x.com/RedChip/status/1978869931107066084) [@RedChip](/creator/x/RedChip) 2025-10-16T17:05Z 5898 followers, XXX engagements


"🔔 Starting Soon: Phoenix Motor $PEVM Live Investor Webinar Join us now and hear how Phoenix is building the future of EVs starting with $200M+ in revenue opportunities. 🔗 $PEVM $BYD $LEV $TSLA $RIVN"  
[X Link](https://x.com/RedChip/status/1962968814208819510) [@RedChip](/creator/x/RedChip) 2025-09-02T20:00Z 5898 followers, XXX engagements


"📊 BTCS $BTCS: An Ethereum-First Public Blockchain Company In just XX seconds see how @NasdaqBTCS is scaling Ethereum infrastructure with: Proprietary Builder+ platform driving block building revenue Validator node operations generating staking rewards A DeFi/TradFi flywheel designed to enhance shareholder value Watch our quick overview and discover why $BTCS is positioned as one of the most sophisticated public Ethereum plays. Overview Here: $BTCS $COIN $RIOT $HIVE $MARA $NVDA $ETH $SQ"  
[X Link](https://x.com/RedChip/status/1970830583132549535) [@RedChip](/creator/x/RedChip) 2025-09-24T12:40Z 5898 followers, 55.2K engagements


"GreenPower $GP up +12% following launch of New Mexico electric school bus program. $GP $TSLA $RIVN $LI $BYD $F $LEV $BLBD $REVG $EML $AAME $WKHS"  
[X Link](https://x.com/RedChip/status/1973091857979564464) [@RedChip](/creator/x/RedChip) 2025-09-30T18:25Z 5898 followers, XXX engagements


"💡 The Future of Drug Development in Just XX Seconds BullFrog AI $BFRG offers a quick look at how its BullFrog Data Networks platform powered by proprietary bfLEAP technology is helping biopharma companies improve drug discovery and development outcomes. Why It Matters to Investors: AI-Driven Efficiency: $BFRG's platform uncovers hidden insights in complex datasets accelerating clinical trials and drug repurposing. Market-Ready Solutions: Designed to help resource-limited biopharma firms optimize R&D while supporting larger enterprises in reducing drug development risks. Strategic"  
[X Link](https://x.com/RedChip/status/1975175481155559513) [@RedChip](/creator/x/RedChip) 2025-10-06T12:25Z 5898 followers, 65.5K engagements


"🎙 BullFrog AI $BFRG: Exclusive Interview with CEO Vin Singh: Unlocking the Future of AI in Drug Discovery $BFRG is changing the game for drug development and CEO Vin Singh breaks down how in this must-watch interview. From their proprietary bfLEAP technology to the launch of BullFrog Data Networks hear how the company is accelerating clinical breakthroughs and driving smarter R&D decisions especially for small and mid-sized biopharma players. Why Investors Should Tune In: Addressing a $204B+ R&D Market with scalable AI tools that cut costs and timelines Strategic partnerships with"  
[X Link](https://x.com/RedChip/status/1975537911769522374) [@RedChip](/creator/x/RedChip) 2025-10-07T12:25Z 5898 followers, XXX engagements


"🚨 Drug development is broken: XX% failure rate $200B wasted annually. AI could be the fix. Bullfrog AI $BFRG is at the forefront with its bfLEAP platform already in use through exclusive collaborations in brain disorders and cancer. Watch this deep dive to learn more: $BFRG $ABBV $GILD $MRNA $SDGR $RXRX $NVDA"  
[X Link](https://x.com/RedChip/status/1975900235747426560) [@RedChip](/creator/x/RedChip) 2025-10-08T12:25Z 5898 followers, 63.6K engagements


"📢 Unlock the Future of Cancer Treatment in Just XX Seconds @CalidiBio $CLDI invites investors to watch its brief company overview video spotlighting its next-gen immuno-oncology platforms designed to target high-impact cancer markets worth up to $XX billion annually. Why It Matters for Investors: Multiple Clinical Programs: Advancing treatments for glioblastoma triple-negative breast cancer lung cancer and more. Breakthrough Delivery Platforms: Protect and enhance the power of oncolytic viruses improving patient outcomes. Strong Pipeline & Analyst Confidence: Three buy ratings with an"  
[X Link](https://x.com/RedChip/status/1977719746641502685) [@RedChip](/creator/x/RedChip) 2025-10-13T12:55Z 5899 followers, 63.3K engagements


"🎥 @NioCorp $NB: XX Seconds Investors Should See Construction-ready U.S. critical minerals project with all major permits secured Offtake visibility: XX% of planned niobium output under long-term agreements plus the largest scandium sales deal on record Financing momentum: U.S. EXIM processing about $800M in debt with potential $400M in additional ECA support and a Department of War grant of up to $10M Scandium strengthens aluminum and niobium strengthens steel: vital for aerospace and defense applications where lighter stronger alloys drive performance. Watch our 30-second overview: $NB $MP"  
[X Link](https://x.com/RedChip/status/1977744894018928853) [@RedChip](/creator/x/RedChip) 2025-10-13T14:35Z 5898 followers, 64.7K engagements


"🧬 $LTRN: AI Platform Transforms Drug Discovery @LanternPharmas RADR platform dramatically speeds up early-stage cancer drug research. Why This Matters to Investors: XX% shorter development timelines XX% reduction in trial costs XX higher odds of clinical success Learn more: $LTRN $SDGR $RXRX $NVDA $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1977752474652991688) [@RedChip](/creator/x/RedChip) 2025-10-13T15:05Z 5898 followers, 70.8K engagements


"🧬 Aptevo Therapeutics $APVO: XXX% Remission in Cohort X Reinforces Mipletamigs Differentiated Position in AML Aptevo announced a XXX% remission rate (CR/CRi) in Cohort X of its RAINIER trial evaluating mipletamig its first-in-class CD123 x CD3 bispecific antibody in combination with venetoclax + azacitidine for newly diagnosed AML patients unfit for intensive chemotherapy. Crucially no dose-limiting toxicities or cytokine release syndrome (CRS) have been observed to date across the trial. Why It Matters: High-Impact Efficacy: XXX% remission in Cohort X with XX% of patients achieving"  
[X Link](https://x.com/RedChip/status/1978070835794497942) [@RedChip](/creator/x/RedChip) 2025-10-14T12:10Z 5899 followers, 47.3K engagements


"🚨 Americas next mineral crisis is unfolding and @NovaMinerals $NVA could be at the center of the solution. China and Russia dominate the global antimony supply: a critical element for EVs energy storage and defense. $NVA's Estelle Project in Alaska offers a rare U.S. source plus a massive multi-million-ounce gold deposit to anchor it. Critical minerals. Tier X gold. One project massive potential. Discover why $NVA could be a game-changer: $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1978104761715953783) [@RedChip](/creator/x/RedChip) 2025-10-14T14:25Z 5899 followers, 45.8K engagements


"🚨 Drug development is broken: XX% failure rate $200B wasted annually. AI could be the fix. Bullfrog AI $BFRG is at the forefront with its bfLEAP platform already in use through exclusive collaborations in brain disorders and cancer. Watch this deep dive to learn more: $BFRG $ABBV $GILD $MRNA $SDGR $RXRX $NVDA"  
[X Link](https://x.com/RedChip/status/1978436950462775569) [@RedChip](/creator/x/RedChip) 2025-10-15T12:25Z 5898 followers, 40.7K engagements


"📊 BTCS $BTCS: An Ethereum-First Public Blockchain Company In just XX seconds see how @NasdaqBTCS is scaling Ethereum infrastructure with: Proprietary Builder+ platform driving block building revenue Validator node operations generating staking rewards A DeFi/TradFi flywheel designed to enhance shareholder value Watch our quick overview and discover why $BTCS is positioned as one of the most sophisticated public Ethereum plays. Overview Here: $BTCS $COIN $RIOT $HIVE $MARA $NVDA $ETH $SQ"  
[X Link](https://x.com/RedChip/status/1978440728331112949) [@RedChip](/creator/x/RedChip) 2025-10-15T12:40Z 5898 followers, XXX engagements


"📈 Gorilla Technology $GRRR: Analyst Target Raised to $XX Amid Transformative Growth Alliance Global Partners has nearly doubled its price target on @GorillaTechGrp lifting it to $XX per share. The upgrade follows the companys $1.44B partnership with Freyer to build AI-powered data center infrastructure in Southeast Asia. Why Investors Should Tune In: Backlog Expansion: AGP projects an incremental $100M added to $GRRR's backlog up sharply from pre-deal levels of $85M. Earnings Outlook: 2026 adjusted EBITDA forecast raised from $28M to $89M on just the first $300M phase of the Freyer contract."  
[X Link](https://x.com/RedChip/status/1978458368328045035) [@RedChip](/creator/x/RedChip) 2025-10-15T13:50Z 5899 followers, 44K engagements


"🔴 Going Live at 4:15 PM EST Join @FatPipe_Inc $FATN CEO Ragula Bhaskar for a live investor webinar + Q&A. 🔗 $FATN $AVGO $CSCO $ORCL $HPE $FTNT $FYBR $CRWD $DDOG"  
[X Link](https://x.com/RedChip/status/1978551488008888669) [@RedChip](/creator/x/RedChip) 2025-10-15T20:00Z 5898 followers, XXX engagements


"🎥 Lantern Pharma $LTRN: Precision Oncology Powered by AI In our recent interview CEO Panna Sharma detailed how @LanternPharma is leveraging its RADR AI platform to accelerate cancer drug development and cut early-stage costs by up to 80%. Key Takeaways for Investors: Global Oncology AI Platform: RADR integrates 200B+ datapoints to guide precision drug development reduce costs and improve trial success rates. Clinical Pipeline: Three assets in trials - LP-300 (Phase X $4B non-small cell lung cancer never-smoker market) LP-184 (DDR-deficient tumors $10B+ potential) LP-284 (aggressive B-cell"  
[X Link](https://x.com/RedChip/status/1978839620310769673) [@RedChip](/creator/x/RedChip) 2025-10-16T15:05Z 5899 followers, 37.3K engagements


"🎙 Must-Watch Interview: Fraser Atkinson CEO of @GreenPowerBus Talks EV Strategy & Growth $GP is driving the electrification of transportation with a purpose-built all-electric lineup of buses and trucks. With 900+ zero-emission vehicles built and $90M+ in revenue generated over the past three years the company is capitalizing on strong regulatory tailwinds and growing demand for clean transit solutions. Why Investors Should Tune In: Undervalued Opportunity: Trades at 1x TTM sales well below peers like Workhorse $WKHS. Profitability Edge: Only peer with positive gross profit. Strategic"  
[X Link](https://x.com/RedChip/status/1979181871570252083) [@RedChip](/creator/x/RedChip) 2025-10-17T13:45Z 5899 followers, 26.4K engagements


"🎥 Nova Minerals: CEO Chris Gerteisen on Gold & Antimony Strategy @NovaMinerals $NVA is advancing its XXX sq. mile Estelle Project in Alaska already defining nearly 10Moz of gold and uncovering high-grade antimony: a critical mineral now in U.S. defense focus. Why It Matters: With gold and antimony both at record highs $NVA is uniquely positioned at the intersection of precious metals growth and critical U.S. supply chain security. Watch CEO Chris Gerteisens full interview for insights on strategy milestones and the road to production: $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH"  
[X Link](https://x.com/RedChip/status/1979191925463732646) [@RedChip](/creator/x/RedChip) 2025-10-17T14:25Z 5898 followers, XXX engagements


"📢 XORTX $XRTX: Targeting 2H25 IND Submission in Gout XORTX has initiated IND preparation for XRx-026 (XORLO) engaging @Allucent_CRO to support regulatory strategy and clinical development. The IND package will include the clinical plan and a fed vs. fasted pharmacologic study of XORLO with submission targeted for the second half of 2025. Why This Matters for Investors Clear FDA Pathway: April 2025 Type B meeting outlined the steps to NDA submission including IND filing clinical and commercial supply with stability data a fed vs. fasted absorption study and compilation for NDA. XORLO is a"  
[X Link](https://x.com/RedChip/status/1963227542950662325) [@RedChip](/creator/x/RedChip) 2025-09-03T13:08Z 5896 followers, XXX engagements


"📢 X Week Until the XORTX $XRTX Live Investor Webinar Dont miss this opportunity to hear directly from CEO Dr. Allen Davidoff about XORTXs lead program XRx-026 and the path toward a new standard in gout treatment. Learn how XORLO could reshape care for underserved gout patients Review regulatory milestones and progress toward NDA submission Get your questions answered during the live Q&A Sept. XX 4:15 PM EST Register Now: $XRTX $AMGN $SYBX $ANIP $FBIO $SELB $PFE"  
[X Link](https://x.com/RedChip/status/1963234800505876741) [@RedChip](/creator/x/RedChip) 2025-09-03T13:37Z 5896 followers, XXX engagements


"📈 XORTX Therapeutics $XRTX: 30-second brief for investors $XRTX is moving its gout program toward a U.S. approval filing in about XX months targeting patients who cannot tolerate allopurinol. Key de-risking steps are in place: FDA feedback received in April patient study completed to support the filing EU patent granted and recent financing to fund manufacturing and launch prep. Estimated market size around $700M per year. Why it matters: Near-term regulatory catalyst with defined milestones Focus on an underserved patient segment Strengthened IP and clear U.S./EU pathways Multiple upcoming"  
[X Link](https://x.com/RedChip/status/1963261983173554391) [@RedChip](/creator/x/RedChip) 2025-09-03T15:25Z 5893 followers, XXX engagements


"📅 Today: XORTX Therapeutics $XRTX Investor Webinar Join us at 4:15 PM EST to hear CEO Dr. Allen Davidoff detail the path forward for XRx-026 and the $700M gout treatment market. 🔗 $XRTX $AMGN $SYBX $ANIP $FBIO $SELB $PFE"  
[X Link](https://x.com/RedChip/status/1965770256514773269) [@RedChip](/creator/x/RedChip) 2025-09-10T13:32Z 5896 followers, XXX engagements


"🫁 Lung Cancer Rising in Non-Smokers - Heres How @LanternPharma $LTRN Is Responding $LTRN's lead candidate LP-300 is designed specifically for this growing patient group. In its Phase X Harmonic trial LP-300 has demonstrated an XX% clinical benefit rate in never smokers with Non-Small Cell Lung Cancer (NSCLC). In one case achieving a complete durable response in the targeted cancer lesions following treatment. 💡 Why Investors Should Pay Attention: 150000 new cases annually of NSCLC in never smokers LP-300 targets key TKI mutations common in these patients (EGFR ALK MET) $4B+ global market"  
[X Link](https://x.com/RedChip/status/1968692772640039009) [@RedChip](/creator/x/RedChip) 2025-09-18T15:05Z 5896 followers, XXX engagements


"🧬 @LanternPharma: Broad AI-Driven Pipeline $LTRN's pipeline now covers XX lead drug programs across multiple cancer types many driven by its AI platform. Why This Matters to Investors: XX total programs (5 in clinic) Targets cancers from lung to brain to pediatric Protected by 100+ patents Learn more: $LTRN $SDGR $RXRX $NVDA $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1969055143678070861) [@RedChip](/creator/x/RedChip) 2025-09-19T15:05Z 5896 followers, XXX engagements


"📢 Today at XX AM EST: D. Boral Capital hosts a panel discussion with Enlivex $ENLV. Join host Jason Kolbert Managing Director of Healthcare Research at D. Boral to discuss Enlivex's recent positive knee OA clinical results with the worlds leading experts in the field of musculoskeletal biology. 🔗 $ENLV $JNJ $ABBV $MRK $AZN $LLY $PFE $BMY $NVS $AXSM $XENE $USPH $BVS"  
[X Link](https://x.com/RedChip/status/1973000900957360630) [@RedChip](/creator/x/RedChip) 2025-09-30T12:24Z 5897 followers, XXX engagements


"🧬 @LanternPharma: Broad AI-Driven Pipeline $LTRN's pipeline now covers XX lead drug programs across multiple cancer types many driven by its AI platform. Why This Matters to Investors: XX total programs (5 in clinic) Targets cancers from lung to brain to pediatric Protected by 100+ patents Learn more: $LTRN $SDGR $RXRX $NVDA $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1974128565441425851) [@RedChip](/creator/x/RedChip) 2025-10-03T15:05Z 5896 followers, 70.6K engagements


"💡 FatPipe Launches Total Security XXX - A Unified Cybersecurity Platform for Enterprises @FatPipe_Inc $FATN announced the general availability of Total Security XXX an all-in-one network and cybersecurity platform that consolidates SD-WAN advanced firewall intrusion prevention email security and SIEM into a single stack. Why This Matters to Investors: Expanding Market Opportunity: Simplifies complex multi-vendor security for millions of small and mid-sized businesses worldwide. Integrated Architecture: Combines SD-WAN DDoS mitigation email sandboxing and data loss prevention under one policy"  
[X Link](https://x.com/RedChip/status/1975197543043576082) [@RedChip](/creator/x/RedChip) 2025-10-06T13:52Z 5895 followers, XXX engagements


"🧬 $LTRN: AI Platform Transforms Drug Discovery @LanternPharmas RADR platform dramatically speeds up early-stage cancer drug research. Why This Matters to Investors: XX% shorter development timelines XX% reduction in trial costs XX higher odds of clinical success Learn more: $LTRN $SDGR $RXRX $NVDA $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1975215761560871223) [@RedChip](/creator/x/RedChip) 2025-10-06T15:05Z 5896 followers, 64K engagements


"🎥 30-Second Investor Snapshot on Trinity Biotech $TRIB Trinity Biotech is making bold moves in diagnostics and diabetes care expanding into the high-growth wearable biosensor market. Why This Matters for Investors: Strategic Expansion: Recent acquisition of Waveforms biosensor assets positions $TRIB to tap into the booming continuous glucose monitoring (CGM) space. Global Reach: Active in 75+ countries with established diagnostic products targeting infectious diseases and diabetes management. Growth Potential: Combining clinical diagnostics with wearable tech for long-term revenue"  
[X Link](https://x.com/RedChip/status/1975576954649665863) [@RedChip](/creator/x/RedChip) 2025-10-07T15:00Z 5894 followers, XXX engagements


"📊 BTCS $BTCS: An Ethereum-First Public Blockchain Company In just XX seconds see how @NasdaqBTCS is scaling Ethereum infrastructure with: Proprietary Builder+ platform driving block building revenue Validator node operations generating staking rewards A DeFi/TradFi flywheel designed to enhance shareholder value Watch our quick overview and discover why $BTCS is positioned as one of the most sophisticated public Ethereum plays. Overview Here: $BTCS $COIN $RIOT $HIVE $MARA $NVDA $ETH $SQ"  
[X Link](https://x.com/RedChip/status/1975904010969256202) [@RedChip](/creator/x/RedChip) 2025-10-08T12:40Z 5890 followers, 70.5K engagements


"🎥 FatPipe $FATN CEO Interview: Inside a Profitable High-Margin Software Business Dont miss this exclusive conversation with Ragula Bhaskar PhD President & CEO of @FatPipe_Inc $FATN a leader in secure software-defined networking. Why Investors Should Watch: Positioned at the intersection of SD-WAN SASE and NMS: a $49B+ TAM by 2030 90%+ gross margins and a recurring revenue model Global footprint with over 2500 enterprise customers Backed by patented tech and a pure-play focus on mission-critical infrastructure FatPipe is delivering results and scaling smart. Watch now: $FATN $AVGO $CSCO $ORCL"  
[X Link](https://x.com/RedChip/status/1975915357148778730) [@RedChip](/creator/x/RedChip) 2025-10-08T13:25Z 5896 followers, 58.2K engagements


"📢 One Week Away: @FatPipe_Inc $FATN Investor Webinar - Reserve Your Spot Hear directly from Ragula Bhaskar Co-Founder & CEO as he shares $FATN's strategy for scaling global SD-WAN solutions with 90%+ margins and robust recurring revenue. Company Highlights: XXXX% net margin (TTM) 35%+ adj. EBITDA margin Expanding U.S. India and Southeast Asia presence Oct. XX at 4:15 PM EST Secure Your Seat: $FATN $AVGO $CSCO $ORCL $HPE $FTNT $FYBR $CRWD $DDOG"  
[X Link](https://x.com/RedChip/status/1975922158908965335) [@RedChip](/creator/x/RedChip) 2025-10-08T13:52Z 5892 followers, 71.9K engagements


"🧬 $LTRN: Rapid Pipeline Expansion @LanternPharma has launched XX new drug development programs in the last X years rapidly growing its oncology portfolio. Why This Matters to Investors: XX programs initiated since 2023 Active Phase 1/2 trials across multiple cancers Expanding pipeline broadens R&D risk profile Learn more: $LTRN $SDGR $RXRX $NVDA $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1975940511849496685) [@RedChip](/creator/x/RedChip) 2025-10-08T15:05Z 5896 followers, 66K engagements


"📈 XORTX Therapeutics $XRTX: 30-second brief for investors $XRTX is moving its gout program toward a U.S. approval filing in about XX months targeting patients who cannot tolerate allopurinol. Key de-risking steps are in place: FDA feedback received in April patient study completed to support the filing EU patent granted and recent financing to fund manufacturing and launch prep. Estimated market size around $700M per year. Why it matters: Near-term regulatory catalyst with defined milestones Focus on an underserved patient segment Strengthened IP and clear U.S./EU pathways Multiple upcoming"  
[X Link](https://x.com/RedChip/status/1975945555894280631) [@RedChip](/creator/x/RedChip) 2025-10-08T15:25Z 5896 followers, 66.9K engagements


"🤖 Lantern Pharma $LTRN: AI is accelerating safer more precise oncology drug development Whats powering the story: RADR leverages 200B plus oncology datapoints to identify candidates optimize patient targeting and cut early development time by XX% and cost by up to 80%. XX programs launched in XX months with patient response predictions validated at greater than XX% accuracy. Three clinical assets advancing: LP-300 Phase X in never-smoker NSCLC LP-184 Phase X in multiple solid tumors including GBM with Fast Track and Orphan designations and LP-284 Phase X for aggressive B-cell lymphomas with"  
[X Link](https://x.com/RedChip/status/1976287351501451645) [@RedChip](/creator/x/RedChip) 2025-10-09T14:03Z 5896 followers, 51.9K engagements


"🎥 Lantern Pharma $LTRN: Precision Oncology Powered by AI In our recent interview CEO Panna Sharma detailed how @LanternPharma is leveraging its RADR AI platform to accelerate cancer drug development and cut early-stage costs by up to 80%. Key Takeaways for Investors: Global Oncology AI Platform: RADR integrates 200B+ datapoints to guide precision drug development reduce costs and improve trial success rates. Clinical Pipeline: Three assets in trials - LP-300 (Phase X $4B non-small cell lung cancer never-smoker market) LP-184 (DDR-deficient tumors $10B+ potential) LP-284 (aggressive B-cell"  
[X Link](https://x.com/RedChip/status/1976302904576290950) [@RedChip](/creator/x/RedChip) 2025-10-09T15:05Z 5896 followers, 66.6K engagements


"🧬 @LanternPharma: Broad AI-Driven Pipeline $LTRN's pipeline now covers XX lead drug programs across multiple cancer types many driven by its AI platform. Why This Matters to Investors: XX total programs (5 in clinic) Targets cancers from lung to brain to pediatric Protected by 100+ patents Learn more: $LTRN $SDGR $RXRX $NVDA $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1976665305137999879) [@RedChip](/creator/x/RedChip) 2025-10-10T15:05Z 5896 followers, XXX engagements


"From DoW-funding enables @NovaMinerals $NVA to accelerate next phase of strategy to onshore US antimony production in Alaska. Get the whole story: $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1977818031993585963) [@RedChip](/creator/x/RedChip) 2025-10-13T19:25Z 5893 followers, XXX engagements


"🚨 X Day Left: FatPipe $FATN Investor Webinar Dont miss insights from Ragula Bhaskar as he outlines growth across SD-WAN SASE and NMS: markets set to exceed $49B by 2030. 📆 Tomorrow  4:15 PM EST 🔗 Register Here: $FATN $AVGO $CSCO $ORCL $HPE $FTNT $FYBR $CRWD $DDOG"  
[X Link](https://x.com/RedChip/status/1978069298368180421) [@RedChip](/creator/x/RedChip) 2025-10-14T12:04Z 5896 followers, XXX engagements


"📺 BioVie $BIVI: CEO Cuong Do Discusses Alzheimers Trial Liver Therapy Breakthroughs and Whats Next Investors don't miss our latest interview with $BIVI CEO Cuong Do as he breaks down the company's pivotal clinical programs and upcoming milestones: Alzheimers in Focus: A potentially pivotal Phase X trial of NE3107 in mild-to-moderate Alzheimer's is underway: targeting one of the worlds most urgent unmet medical needs. Liver Disease Innovation: BIV201 aims to treat life-threatening complications of liver cirrhosis linked to hepatitis NASH and alcohol-related damage. Why It Matters: $BIVI is"  
[X Link](https://x.com/RedChip/status/1978439467200324008) [@RedChip](/creator/x/RedChip) 2025-10-15T12:35Z 5890 followers, XXX engagements


"🧬 XX Degrees Pharma $SXTP: Early Success in Tackling Relapsing Babesiosis with Tafenoquine XX Degrees Pharmaceuticals has reported no detection of Babesia infection in the first patient treated in its relapsing babesiosis study using tafenoquine an important milestone in its FDA pathway. Why This Matters to Investors: Breakthrough Therapy Designation request submitted to the FDA No current FDA-approved treatment for babesiosis a life-threatening tick-borne illness in immunosuppressed patients The full study is expected to conclude by October 2026 aiming to confirm tafenoquines high cure rate"  
[X Link](https://x.com/RedChip/status/1978441405195223084) [@RedChip](/creator/x/RedChip) 2025-10-15T12:42Z 5896 followers, XXX engagements


"😎 $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1978443242891841616) [@RedChip](/creator/x/RedChip) 2025-10-15T12:50Z 5896 followers, XXX engagements


"🔔 NioCorp $NB: Exclusive Investor Webinar with CEO Mark Smith & COO Scott Honan Join @NioCorps leadership team for a live investor webinar on Monday October XX at 11:00 AM ET. Get direct insights on: Progress toward project financing for the Elk Creek Critical Minerals Project Recent $162.8M cash position and capital raise details U.S. DoW support and long-term offtake agreements Save your seat now: $NB $MP $ARA $ILU $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO"  
[X Link](https://x.com/RedChip/status/1978453832494453114) [@RedChip](/creator/x/RedChip) 2025-10-15T13:32Z 5894 followers, XXX engagements


"🚨 Tomorrow @JackpotDigital $JPOTF CEO Jake Kalpakian goes live at 4:15 PM EST. Dont miss insights into the companys expansion and growth opportunities. 🔗 Register here: $JPOTF $MGM $LVS $CZR $DKNG $WYNN $BYD $VICI $IGT $PENN"  
[X Link](https://x.com/RedChip/status/1978455594693460418) [@RedChip](/creator/x/RedChip) 2025-10-15T13:39Z 5891 followers, XXX engagements


"📈 XORTX Therapeutics $XRTX: 30-second brief for investors $XRTX is moving its gout program toward a U.S. approval filing in about XX months targeting patients who cannot tolerate allopurinol. Key de-risking steps are in place: FDA feedback received in April patient study completed to support the filing EU patent granted and recent financing to fund manufacturing and launch prep. Estimated market size around $700M per year. Why it matters: Near-term regulatory catalyst with defined milestones Focus on an underserved patient segment Strengthened IP and clear U.S./EU pathways Multiple upcoming"  
[X Link](https://x.com/RedChip/status/1978482273969156340) [@RedChip](/creator/x/RedChip) 2025-10-15T15:25Z 5896 followers, XXX engagements


"Join FatPipe's CEO for our investor webinar: live now $FATN $AVGO $CSCO $ORCL $HPE $FTNT $FYBR $CRWD $DDOG"  
[X Link](https://x.com/RedChip/status/1978558504039309788) [@RedChip](/creator/x/RedChip) 2025-10-15T20:28Z 5890 followers, XXX engagements


"🎥 @ASPIsotopes: One-Minute Insight into a High-Impact Growth Story $ASPI is pioneering the next frontier of isotope production right as global demand surges in nuclear medicine quantum computing and clean energy. Backed by $60M+ in cash and a scalable business model $ASPI is now commercializing key isotopes like Ytterbium-176 and Carbon-14 under long-term supply agreements. Why This Matters for Investors Transition to Revenue: From R&D to commercialization in 2025 Strategic Partnerships: Backed by TerraPower and South Africas Necsa Breakthrough Technology: Proprietary Aerodynamic and Quantum"  
[X Link](https://x.com/RedChip/status/1978796831006957947) [@RedChip](/creator/x/RedChip) 2025-10-16T12:15Z 5892 followers, XXX engagements


"🚀 BioVie Inc. Targeting Major Breakthroughs in Neurology & Liver Disease $BIVI is advancing innovative therapies in high-need markets including Alzheimers Parkinsons Long COVID and liver cirrhosis. With multiple clinical-stage assets and a fully funded Parkinsons Phase 2b trial launching in late 2024 the company is gearing up for a catalyst-rich year ahead. Why This Matters for Investors: Multiple Shots on Goal: Active programs in Alzheimers (Phase 3) Parkinsons (Phase 2b) Long COVID (Phase 2) and liver disease (Phase 3-ready). Regulatory Momentum: FDA Fast Track status for BIV201 in liver"  
[X Link](https://x.com/RedChip/status/1978801878214332643) [@RedChip](/creator/x/RedChip) 2025-10-16T12:35Z 5888 followers, XXX engagements


"🎥 Greenwich LifeSciences $GLSI: CEO Snehal Patel Discusses GP2 Immunotherapy and Phase III Strategy In our most recent interview CEO Snehal Patel outlines the companys clinical and strategic roadmap for GP2 an immunotherapy designed to prevent breast cancer recurrences in HER2-positive patients following surgery. Key Takeaways for Investors: Robust Phase IIb Data: GP2 achieved over XX% reduction in recurrence rates over five years significantly outperforming existing therapies in the adjuvant setting. Strong Safety Profile: No serious adverse events reported across XXX patients in four"  
[X Link](https://x.com/RedChip/status/1978818212507631774) [@RedChip](/creator/x/RedChip) 2025-10-16T13:40Z 5890 followers, XXX engagements


"🚨 In times of uncertainty gold has always been the ultimate safe haven asset; @NovaMinerals is sitting on a massive XXX million ounce gold resource in one at its Estelle Project in Alaskas legendary Tintina Gold Belt. $NVA's district-scale opportunity currently valued at a fraction of its peers also includes a rich antimony resource that offers additional upside as mineral supply chains tighten globally. See why $NVA could be the next big gold story: $NVA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1978829539368141208) [@RedChip](/creator/x/RedChip) 2025-10-16T14:25Z 5892 followers, XXX engagements


"🎯 Todays the day @JackpotDigital $JPOTF CEO Jake Kalpakian to host our live investor webinar at 4:15 PM EST. Seats filling fast - register now: $JPOTF $MGM $LVS $CZR $DKNG $WYNN $BYD $VICI $IGT $PENN"  
[X Link](https://x.com/RedChip/status/1978837338437382437) [@RedChip](/creator/x/RedChip) 2025-10-16T14:56Z 5891 followers, XXX engagements


"🫁 Lung Cancer Rising in Non-Smokers - Heres How @LanternPharma $LTRN Is Responding $LTRN's lead candidate LP-300 is designed specifically for this growing patient group. In its Phase X Harmonic trial LP-300 has demonstrated an XX% clinical benefit rate in never smokers with Non-Small Cell Lung Cancer (NSCLC). In one case achieving a complete durable response in the targeted cancer lesions following treatment. 💡 Why Investors Should Pay Attention: 150000 new cases annually of NSCLC in never smokers LP-300 targets key TKI mutations common in these patients (EGFR ALK MET) $4B+ global market"  
[X Link](https://x.com/RedChip/status/1978839613381751126) [@RedChip](/creator/x/RedChip) 2025-10-16T15:05Z 5895 followers, XXX engagements


"🚨 Starting soon @JackpotDigital $JPOTF CEO Jake Kalpakian live investor webinar at 4:15 PM EST. 👉 Last chance to join: $JPOTF $MGM $LVS $CZR $DKNG $WYNN $BYD $VICI $IGT $PENN"  
[X Link](https://x.com/RedChip/status/1978913882258247795) [@RedChip](/creator/x/RedChip) 2025-10-16T20:00Z 5891 followers, XXX engagements


"Join @JackpotDigital $JPOTF's CEO for our investor webinar followed by a Q&A session: live now $JPOTF $MGM $LVS $CZR $DKNG $WYNN $BYD $VICI $IGT $PENN"  
[X Link](https://x.com/RedChip/status/1978922146840641653) [@RedChip](/creator/x/RedChip) 2025-10-16T20:33Z 5891 followers, XXX engagements


"PRE-MARKET MOVER ALERT: Xortx Therapeutics $XRTX up +43% on +400x average daily volume in premarket trading following news of acquisition of renal anti-fibrotic therapeutic program. Read the full news: $XRTX $AMGN $SYBX $ANIP $FBIO $SELB $PFE"  
[X Link](https://x.com/RedChip/status/1979161356705137076) [@RedChip](/creator/x/RedChip) 2025-10-17T12:23Z 5896 followers, XXX engagements


"💊 XORTX Therapeutics $XRTX: Expands Kidney Disease Pipeline with Strategic Acquisition from Vectus Biosystems XORTX Therapeutics has entered into a binding term sheet to acquire Vectus Biosystems Renal Anti-Fibrotic Therapeutic Program featuring VB4-P5 a novel small molecule with potential to treat both rare and large-market kidney diseases. Learn more about the acquisition and XORTXs kidney disease pipeline: $XRTX $AMGN $SYBX $ANIP $FBIO $SELB $PFE"  
[X Link](https://x.com/RedChip/status/1979166859996905568) [@RedChip](/creator/x/RedChip) 2025-10-17T12:45Z 5896 followers, XXX engagements


"Tomorrow at XX AM EST: D. Boral Capital hosts a biotech webinar featuring Enlivex $ENLV. Hosted by Jason Kolbert the discussion will spotlight Enlivexs recent osteoarthritis data with insights from Vice Chairman Dr. Roger Pomerantz and leading musculoskeletal biology experts. 🔗 $ENLV $JNJ $ABBV $MRK $AZN $LLY $PFE $BMY $NVS $AXSM $XENE $USPH $BVS"  
[X Link](https://x.com/RedChip/status/1972673751071224083) [@RedChip](/creator/x/RedChip) 2025-09-29T14:44Z 5897 followers, XXX engagements


"🎥 FatPipe $FATN CEO Interview: Inside a Profitable High-Margin Software Business Dont miss this exclusive conversation with Ragula Bhaskar PhD President & CEO of @FatPipe_Inc $FATN a leader in secure software-defined networking. Why Investors Should Watch: Positioned at the intersection of SD-WAN SASE and NMS: a $49B+ TAM by 2030 90%+ gross margins and a recurring revenue model Global footprint with over 2500 enterprise customers Backed by patented tech and a pure-play focus on mission-critical infrastructure FatPipe is delivering results and scaling smart. Watch now: $FATN $AVGO $CSCO $ORCL"  
[X Link](https://x.com/RedChip/status/1978452073634050517) [@RedChip](/creator/x/RedChip) 2025-10-15T13:25Z 5897 followers, XXX engagements


"📢 Today at 4:15 PM EST: @FatPipe_Inc $FATN Investor Webinar High-margin recurring-revenue tech innovator in global SD-WAN. Join our live Q&A with CEO Ragula Bhaskar. 🎯 Register now: $FATN $AVGO $CSCO $ORCL $HPE $FTNT $FYBR $CRWD $DDOG"  
[X Link](https://x.com/RedChip/status/1978455594689335682) [@RedChip](/creator/x/RedChip) 2025-10-15T13:39Z 5898 followers, XXX engagements


"📡 FatPipe $FATN: Completes 108-Site SD-WAN Rollout for Regional Bank @FatPipe_Inc has finalized a major SD-WAN deployment across XXX branches data centers and remote offices for a leading regional bank standardizing its entire network on a single $FATN architecture. Read the Full Announcement: $FATN $AVGO $CSCO $ORCL $HPE $FTNT $FYBR $CRWD $DDOG"  
[X Link](https://x.com/RedChip/status/1978867253807292424) [@RedChip](/creator/x/RedChip) 2025-10-16T16:54Z 5897 followers, XXX engagements


"🔔 BullFrog AI $BFRG Webinar Starts in XX Minutes Join now to explore how AI is reshaping biopharma R&D. 🔗 @JCVenterInst @LieberInstitute $BFRG $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1948110925447172606) [@RedChip](/creator/x/RedChip) 2025-07-23T20:00Z 5898 followers, XXX engagements


"💡 The Future of Drug Development in Just XX Seconds BullFrog AI $BFRG offers a quick look at how its BullFrog Data Networks platform powered by proprietary bfLEAP technology is helping biopharma companies improve drug discovery and development outcomes. Why It Matters to Investors: AI-Driven Efficiency: $BFRG's platform uncovers hidden insights in complex datasets accelerating clinical trials and drug repurposing. Market-Ready Solutions: Designed to help resource-limited biopharma firms optimize R&D while supporting larger enterprises in reducing drug development risks. Strategic"  
[X Link](https://x.com/RedChip/status/1977712195698827386) [@RedChip](/creator/x/RedChip) 2025-10-13T12:25Z 5898 followers, 79.4K engagements


"🎥 XX Degrees Pharmaceuticals: Watch the 30-Second Investor Overview XX Degrees Pharmaceuticals $SXTP is advancing next-gen therapies for infectious diseases with a strong focus on late-stage clinical assets. Why Investors Should Watch: Revenue Momentum: ARAKODA malaria prevention sales surged XXX% YoY in Q3 2024. Clinical Expansion: Tafenoquine entering a pivotal trial for babesiosis a growing tick-borne threat with 47000 U.S. cases annually. Capital-Efficient Model: Leverages existing data to accelerate development and reduce risk across its pipeline. See the Big Picture in Just XX Seconds:"  
[X Link](https://x.com/RedChip/status/1977749963162477026) [@RedChip](/creator/x/RedChip) 2025-10-13T14:55Z 5898 followers, 59.2K engagements


"📢 Foremost Clean Energy $FMST: Strategic Advantage in the Athabasca Basin In our latest interview CEO Jason Barnard highlights how @FMSTCleanEnergy's partnership with Denison Mines $DNN and proximity to world-class producers like Cameco set the stage for outsized upside: Why This Matters for Investors: 330000+ acres across XX properties in the Athabasca Basin one of the richest uranium districts in the world Fully funded $6.5M exploration program in 2025 with active drill campaigns at Murphy Lake and Hatchet Lake Direct access to Denisons ISR expertise and data advantage accelerating"  
[X Link](https://x.com/RedChip/status/1978815761356382342) [@RedChip](/creator/x/RedChip) 2025-10-16T13:30Z 5898 followers, 34.4K engagements


"🧬 @LanternPharma: Broad AI-Driven Pipeline $LTRN's pipeline now covers XX lead drug programs across multiple cancer types many driven by its AI platform. Why This Matters to Investors: XX total programs (5 in clinic) Targets cancers from lung to brain to pediatric Protected by 100+ patents Learn more: $LTRN $SDGR $RXRX $NVDA $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1979201999032721462) [@RedChip](/creator/x/RedChip) 2025-10-17T15:05Z 5898 followers, XXX engagements